
James Hoffman
@drjhoffmanmiami
Associate Professor, Myeloma/Amyloidosis Program; Associate Director heme-onc fellowship program at @sylvestercancer at U. Miami; Miami sports fan; father of 3.
ID: 1225723298
https://doctors.umiamihealth.org/provider/James+Edward+Hoffman/524918 27-02-2013 18:05:44
3,3K Tweet
3,3K Followers
1,1K Following


Check out this review on myeloma precursor states: From MGUS to multiple myeloma: Unraveling the unknown of precursor sta... sciencedirect.com/science/articl… Thank you C. Ola Landgren, M.D. James Hoffman, @davidcoffey and the myeloma team for the mentorship and support 🙌 Sylvester Comprehensive Cancer Center

As a 50th birthday present to me, a close friend has thrown out a challenge to match a total of $500 to Dolphins Cancer Challenge for any donations made today! If we raise $500, $500 will be donated. Please share/help if you are able! #OneTeamOneFight dolphinscancerchallenge.com/index.cfm?fuse…

Excited to share new pre-print from the lab! Ben Diamond, MD investigated 580 WGS to define the mutagenic impact of radiotherapy in hematological malignancies. Great collaboration between Heidelberg Myeloma Moffitt Cancer Center Sylvester Comprehensive Cancer Center Memorial Sloan Kettering Cancer Center 1/19


We are thrilled to announce the successful fellowship match for our program UMiami Health System Sylvester Comprehensive Cancer Center Jackson Health System . Please join us in welcoming our new fellows for upcoming academic year.Valentina Ardila Asad Rauf Dan Morgenstern, MD, MSc , Derek Essegian and Jose Forero.




Hem/onc fellowship secret Santa! 🎄🎅🏼Miami Hematology Oncology Program Director Sylvester Comprehensive Cancer Center






Excited to see our fellows actively participating at the FLASCO #Fellows Conference, with two fellows Chinmay Jani Deborah Soong presenting at the Navigation Panel! A fantastic opportunity to connect, collaborate, and contribute.



Announcing 2025–26 Chief Fellows Chinmay Jani & Dr. Amrit Paudel Dr. Jani, former chief resident Mount Auburn Hospital Internal Medicine Residency Harvard Medical School is working on translational/Phase 1 research in lung & GU cancers. Dr. Paudel, former faculty at Georgetown University, focuses on sarcoma research esp Myxofibrosarcoma.





Breaking News: Prothena Corporation has announced that the Phase 3 AFFIRM-AL clinical trial evaluating birtamimab in patients with Mayo Stage IV AL #amyloidosis failed to meet its primary endpoint. Learn more: arci.org/negative-affir…

Our CD38 resistance story is out in Blood Journals Portfolio. We had a great time putting this one together. Big multi-institutional collab!